newsfilter
← Latest News
GlobeNewswire·

Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO

WARMINSTER, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company focused on infectious disease, today announced